Mixed Phenotype/Lineage Leukemia: Has Anything Changed for 2021 on Diagnosis, Classification, and Treatment?
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mixed Phenotype/Lineage Leukemia: Has Anything Changed for 2021 on Diagnosis, Classification, and Treatment?
Authors
Keywords
-
Journal
Current Oncology Reports
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-04-05
DOI
10.1007/s11912-022-01252-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Unsupervised cluster analysis and subset characterization of abnormal erythropoiesis using the bioinformatic Flow‐Self Organizing Maps algorithm
- (2022) Anna Porwit et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Mixed Phenotype Acute Leukemia: Current Approaches to Diagnosis and Treatment
- (2021) Thomas B. Alexander et al. Current Oncology Reports
- Unsupervised Flow Cytometry Analysis Allows for an Accurate Identification of Minimal Residual Disease Assessment in Acute Myeloid Leukemia
- (2021) Jean Philippe Vial et al. Cancers
- Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia
- (2021) Benoît Brethon et al. Frontiers in Oncology
- Update on Acute Leukemias of Ambiguous Lineage
- (2021) Nidhi Aggarwal et al. CLINICS IN LABORATORY MEDICINE
- Unsupervised flow cytometry analysis in hematological malignancies: A new paradigm
- (2021) Marie C. Béné et al. International Journal of Laboratory Hematology
- Pediatric Mixed-Phenotype Acute Leukemia: What’s New?
- (2021) Sandeep Batra et al. Cancers
- Enrichment of Double RUNX1 Mutations in Acute Leukemias of Ambiguous Lineage
- (2021) Gabriele Merati et al. Frontiers in Oncology
- Efficacy of combination of venetoclax with azacitidine or chemotherapy in refractory/relapse acute leukemias of ambiguous lineage, not otherwise specified
- (2021) Kaiqi Liu et al. Experimental Hematology & Oncology
- Use of midostaurin in mixed phenotype acute leukemia with FLT3 mutation: A case series
- (2021) Zoë Tremblay et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Diagnostic Workup of Acute Leukemias of Ambiguous Lineage
- (2020) Sanjay S. Patel et al. AMERICAN JOURNAL OF HEMATOLOGY
- Optimal therapeutic strategies for mixed phenotype acute leukemia
- (2020) Ofir Wolach et al. CURRENT OPINION IN HEMATOLOGY
- Prognostic impact of Philadelphia Chromosome in mixed phenotype acute leukemia ( MPAL ): a cancer registry analysis on real‐world outcome
- (2020) Ayman Qasrawi et al. AMERICAN JOURNAL OF HEMATOLOGY
- The successful use of FLT3 inhibitors in FLT3-positive mixed phenotype acute leukemia
- (2020) Claire Andrews et al. LEUKEMIA & LYMPHOMA
- Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report
- (2020) Meng-Yun Li et al. Biomarker Research
- Multiparameter flow cytometry applications in the diagnosis of mixed phenotype acute leukemia
- (2019) Anna Porwit et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Concomitant use of blinatumomab and donor lymphocyte infusion for mixed-phenotype acute leukemia: a case report with literature review
- (2019) Seren Durer et al. Immunotherapy
- Rewiring the Epigenetic Networks in MLL-Rearranged Leukemias: Epigenetic Dysregulation and Pharmacological Interventions
- (2019) Anthony K. N. Chan et al. Frontiers in Cell and Developmental Biology
- The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia
- (2018) Eytan M. Stein et al. BLOOD
- Acute myeloid/T-lymphoblastic leukaemia (AMTL): a distinct category of acute leukaemias with common pathogenesis in need of improved therapy
- (2018) Alejandro Gutierrez et al. BRITISH JOURNAL OF HAEMATOLOGY
- Complexity of Blocking Bivalent Protein–Protein Interactions: Development of a Highly Potent Inhibitor of the Menin–Mixed-Lineage Leukemia Interaction
- (2018) Dmitry Borkin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis
- (2018) Maria Maruffi et al. LEUKEMIA
- Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes
- (2018) Koichi Takahashi et al. Nature Communications
- The genetic basis and cell of origin of mixed phenotype acute leukaemia
- (2018) Thomas B. Alexander et al. NATURE
- How I treat mixed-phenotype acute leukemia
- (2015) O. Wolach et al. BLOOD
- FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data
- (2015) Sofie Van Gassen et al. CYTOMETRY PART A
- Philadelphia chromosome-positive mixed phenotype acute leukemia in the imatinib era
- (2014) Hiroaki Shimizu et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification
- (2011) E. Matutes et al. BLOOD
- Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10
- (2011) M C Béné et al. LEUKEMIA
- Four- and five-color flow cytometry analysis of leukocyte differentiation pathways in normal bone marrow: A reference document based on a systematic approach by the GTLLF and GEIL
- (2009) Christine Arnoulet et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Biphenotypic, bilineal, ambiguous or mixed lineage: strange leukemias!
- (2009) M. C. Bene HAEMATOLOGICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started